In a 73-year-old man with a BNP of 968 pg/mL, grade 1 diastolic dysfunction, and a left‑ventricular ejection fraction (EF) of 60‑65 %, does this indicate heart failure?

Does BNP of 968 pg/mL in a 73-year-old male with grade 1 diastolic dysfunction and EF 60-65% indicate heart failure?

Yes, this clinical picture is consistent with heart failure with preserved ejection fraction (HFpEF), and the patient should be diagnosed and treated as having heart failure.

Diagnostic Reasoning

The diagnosis of heart failure is fundamentally a clinical syndrome based on symptoms and signs, not solely on test results 1, 2. However, this patient's presentation meets multiple diagnostic criteria for HFpEF:

BNP Elevation Strongly Supports HF Diagnosis

• BNP of 968 pg/mL far exceeds all guideline thresholds for heart failure diagnosis
• The 2022 AHA/ACC/HFSA guidelines recommend BNP ≥35 pg/mL as supportive evidence 3
• The 2009 ACC/AHA guidelines (Class I, Level A recommendation) state that BNP should be measured in patients with dyspnea where HF contribution is uncertain, and this level definitively indicates HF 2, 1
• For HFpEF specifically, suggested diagnostic thresholds are BNP ≥100 pg/mL 4, which this patient exceeds nearly 10-fold

Preserved Ejection Fraction with Diastolic Dysfunction

• EF of 60-65% with grade 1 diastolic dysfunction defines the HFpEF phenotype (LVEF ≥50%) 3, 5
• The presence of diastolic dysfunction provides the structural/functional cardiac abnormality required for HFpEF diagnosis 3, 5
• Even grade 1 (mild) diastolic dysfunction, when accompanied by elevated BNP and symptoms, supports the diagnosis 5

Age-Related Considerations

At 73 years old, this patient falls into the typical demographic for HFpEF, where:

• BNP levels naturally increase with age 6, 4
• However, a level of 968 pg/mL remains markedly elevated even accounting for age
• The 2007 Canadian guidelines note age influences BNP but don't suggest thresholds this high are normal 6

Critical Diagnostic Requirements

The diagnosis cannot be finalized without confirming the presence of HF symptoms and signs 1, 2:

Must Assess For:

• Dyspnea (exertional or at rest)
• Fatigue or exercise intolerance
• Fluid retention signs: peripheral edema, elevated jugular venous pressure, pulmonary rales, ascites
• Volume status: evidence of congestion

Additional Structural Evidence to Seek:

• Left atrial enlargement (left atrial volume index)
• LV hypertrophy or increased LV mass
• E/e' ratio (if ≥15, strongly supports elevated filling pressures) 3

Important Caveats and Pitfalls

BNP Interpretation Nuances:

Factors that could falsely elevate BNP (though unlikely to account for this magnitude):

• Atrial fibrillation 4
• Renal dysfunction 4
• Pulmonary disease, pulmonary embolism 4
• Sepsis 4

Factors that could falsely lower BNP (making the diagnosis even more certain if present):

• Obesity significantly reduces BNP levels 6, 4—if this patient is obese, the "true" cardiac stress is even higher

Grade 1 Diastolic Dysfunction Consideration:

• While grade 1 is "mild," BNP elevation of this magnitude indicates the functional impact is not mild 7
• Research shows that in HFpEF, BNP correlates with elevated filling pressures even when structural abnormalities appear modest 7, 8
• The discordance between "mild" echo findings and markedly elevated BNP suggests either:
  • Underestimation of diastolic dysfunction severity
  • Need for stress echocardiography to unmask exercise-induced elevation in filling pressures 3

Diagnostic Algorithm Application

Using the 2022 AHA/ACC/HFSA diagnostic algorithm 3:

1. ✓ Natriuretic peptide elevation: BNP 968 pg/mL (>>35 pg/mL threshold)
2. ✓ LVEF ≥50%: Patient has 60-65%
3. ✓ Evidence of structural/functional abnormality: Grade 1 diastolic dysfunction present
4. ? Symptoms/signs of HF: Must be confirmed clinically

If symptoms are present, diagnosis is established. If symptoms are absent or unclear, consider:

• H₂FPEF score to assess likelihood 3
• Exercise stress echocardiography with diastolic parameter assessment 3
• Invasive hemodynamic testing if diagnosis remains uncertain 3

Management Implications

Once HF diagnosis is confirmed, this patient requires:

• Aggressive treatment of underlying comorbidities (hypertension, diabetes if present) 3, 9
• Loop diuretics for symptom relief if congestion present 9
• SGLT2 inhibitors (emerging evidence for HFpEF benefit)
• Blood pressure control to <130/80 mmHg 6
• Consideration for ARNI or MRA based on individual factors

This is NOT Stage B HF (asymptomatic LV dysfunction)—the markedly elevated BNP indicates hemodynamically significant disease requiring active HF management 1, 2.